3-amino-N-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxamide → 3-amino-6-[5-chloro-1-(3-hydroxypropyl)-1H-pyrazol-4-yl]-N-methylpyridine-2-carboxamide
Reaction equation
NC1C=CC(C2C=NN(CCCO)C=2)=CC=1C(N(CC)CC)=O.[NH2:24][C:25]1[C:26]([C:40]([NH:42][CH3:43])=[O:41])=[N:27][C:28](B2OC(C)(C)C(C)(C)O2)=[CH:29][CH:30]=1.Br[C:45]1[CH:46]=[N:47][N:48]([CH2:51][CH2:52][CH2:53][OH:54])[C:49]=1[Cl:50]>>[NH2:24][C:25]1[C:26]([C:40]([NH:42][CH3:43])=[O:41])=[N:27][C:28]([C:45]2[CH:46]=[N:47][N:48]([CH2:51][CH2:52][CH2:53][OH:54])[C:49]=2[Cl:50])=[CH:29][CH:30]=1Participants
4
Reactant 3
Product 1
Procedure
Prepared analogously to Compound 3C using 3-amino-N-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxamide (Compound 48D, 284 mg, 1.03 mmol) and 3-(4-bromo-5-chloro-1H-pyrazol-1-yl)propan-1-ol (Compound 49D, 270 mg, 1.1 mmol) to afford 151 mg of the title compound (48%). 1H NMR (400 MHz, CD3OD) δ 8.12 (s, 1H), 7.67 (d, J=8.6 Hz, 1H), 7.20 (d, J=8.6 Hz, 1H), 4.32 (t, J=7.1 Hz, 2H), 3.60 (t, J=6.1 Hz, 2H), 2.94 (s, 3H), 2.06 (quin, J=6.6 Hz, 2H). MS (ESI): m/z=310.20/312.18 [M+H]+. UPLC: tR=0.77 min (UPLC-TOF: polar—2 min).
Sources & evidence
- ORD record
- ord-15a7901d35ca4ceea88faaa99bacac89
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09133224B2
Reaction notes
Loading…